Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)

Open Access

Peer-reviewed

Research Article

Sandeep Juneja,

Affiliation Medicines Patent Pool, Geneva, Switzerland
⨯
Aastha Gupta ,

* E-mail: agupta@medicinespatentpool.org

Affiliation Medicines Patent Pool, Geneva, Switzerland
⨯
Suerie Moon,

Affiliation Harvard T.H. Chan School of Public Health, Boston, United States of America
⨯
Stephen Resch

Affiliation Harvard T.H. Chan School of Public Health, Boston, United States of America
⨯

Reader Comments (0)

Low and middle income countries
Is the Subject Area "Low and middle income countries" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.
Pediatrics
Is the Subject Area "Pediatrics" applicable to this article?

Thanks for your feedback.
Public and occupational health
Is the Subject Area "Public and occupational health" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Global health
Is the Subject Area "Global health" applicable to this article?

Thanks for your feedback.
Patents
Is the Subject Area "Patents" applicable to this article?

Thanks for your feedback.